The common effects GI upset and the fishy odor are dose-related, benign, and reversible, and the controlled trials report good overall tolerability without serious adverse events as a feature
Analyses were conducted in April 2026 and include data from 141 Noom GLP-1Rx Program members who started a GLP-1Rx plan in NovemberDecember 2025 (Sample 1) and 51 Noom GLP-1Rx Program members who started between November 2024 and June 2025 (Sample 2) and responded to a follow-up survey after discontinuation
Benefits Effective Weight Loss: Clinical trials have demonstrated that GLP-1 agonists can lead to significant weight loss, especially in individuals with obesity or overweight conditions
Independent policy experts warn that unsupervised GLP-1 use during menopause carries unique risks, including accelerated muscle and bone loss, which is exactly what medical monitoring is designed to prevent
De media, los pacientes pierden entre 2 y 5 kg en el primer mes, aunque los resultados dependen de cada persona, la dieta y el ejercicio
Our team has supported peptide research programs across universities and private labs since 2014